Paydirt
TM
Insider

Teresa McCarthy

Chief Human Resources Officer

Teresa McCarthy (Chief Human Resources Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $212K of RNA (2,929 sh across 2 lots, as filed), executed Jan 21. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$354K
shares × price, as filed
Last traded
Jan 21
Filed Jan 23
Open performance→
Volume by month
$1.2M$598K$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · sells $1.2MMar 2025 · sells $242KAug 2025 · sells $466KSep 2025 · sells $621KOct 2025 · sells $1.0MJan 2026 · sells $354K
Buys $0 Sells $3.9M

Shares × price, as filed · by filing month · past 24 months

Most traded names
RNA RNA 0 buys · 9 sells 9 filings
Recent filings
RNASALE Avidity Biosciences, Inc. View filing → $212K
2,929 sh across 2 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $142K
1,965 sh × $72.23
Exec Jan 7
Filed Jan 9 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $1.0M
20,000 sh × $50.15
Exec Oct 15 2025
Filed Oct 17 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $621K
15,000 sh × $41.41
Exec Sep 15 2025
Filed Sep 17 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $466K
10,000 sh × $46.56
Exec Aug 15 2025
Filed Aug 15 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $242K
7,778 sh × $31.06
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $364K
11,151 sh × $32.66
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET
RNASALE Avidity Biosciences, Inc. View filing → $832K
25,000 sh × $33.26
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET
More filings →